P. Greaves

Most-cited papers

1. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

   Obbina Ali Fatima Mustafa Sadia Hakam Alfie Nabeel Ashraf Abani Abbas Abbas Abbas Abbasi Abbass Abbott Abdal, O. Abani, A. Abbas, F. Abbas +496 more

   2021The Lancet1,685 citations Open access

   Semantic Scholar

   Save

2. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

   Eugenia Mustafa Sadia Alfie Ashraf Sherif Mohamed Basir Al Abaleke Abbas Abbasi Abbott Abdelaziz Abdelbadiee , E. Abaleke, M. Abbas, Sadia Abbasi +496 more

   2021The Lancet289 citations Open access

   Semantic Scholar

   Save

3. The role of B7 family molecules in hematologic malignancy.

   P. Greaves, J. Gribben

   2013Blood193 citations Open access

   Semantic Scholar

   Save

4. Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells.

   P. Greaves, A. Clear, A. Owen, S. Iqbal +5 more

   2013Blood158 citations Open access

   Semantic Scholar

   Save

5. Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome.

   P. Greaves, A. Clear, R. Coutinho, A. Wilson +6 more

   2013Journal of Clinical Oncology148 citations Open access

   Semantic Scholar

   Save

6. Bone marrow necrosis and fat embolism syndrome in sickle cell disease: increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection.

   D. Tsitsikas, G. Gallinella, Sneha Patel, H. Seligman +2 more

   2014Blood reviews115 citations

   Semantic Scholar

   Save

7. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

   O. A. F. J. K. M. S. H. A. Abani Abbas Abbas Abbas Abbas Abbas Abbasi Abbass, O. Abani, A. Abbas, F. Abbas +496 more

   2023The Lancet103 citations Open access

   Semantic Scholar

   Save

8. Fertility and sexual function in long‐term survivors of haematological malignancy: using patient‐reported outcome measures to assess a neglected area of need in the late effects clinic

   P. Greaves, Shah-Jalal Sarker, K. Chowdhury, Rachel Johnson +6 more

   2014British Journal of Haematology71 citations Open access

   Semantic Scholar

   Save

9. Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOP

   R. Coutinho, A. Clear, E. Mazzola, A. Owen +10 more

   2015Haematologica63 citations Open access

   Semantic Scholar

   Save

10. The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies.

    K. Liapis, A. Clear, A. Owen, R. Coutinho +5 more

    2013Blood57 citations Open access

    Semantic Scholar

    Save

11. Psychosocial factors associated with impact of cancer in longterm haematological cancer survivors

    A. Korszun, Shah-Jalal Sarker, K. Chowdhury, C. Clark +8 more

    2014British Journal of Haematology43 citations Open access

    Semantic Scholar

    Save

12. Management of secondary central nervous system lymphoma

    K. Cwynarski, Tom Cummin, W. Osborne, Joanne Lewis +6 more

    2022British Journal of Haematology21 citations Open access

    Semantic Scholar

    Save

13. Successful outcome of three patients with sickle‐cell disease and fat embolism syndrome treated with intensive exchange transfusion

    P. Greaves, V. Mathew, C. Peters, S. Rowe +2 more

    2016Clinical Case Reports20 citations Open access

    Semantic Scholar

    Save

14. Sweet syndrome as terminal event in ruxolitinib‐treated myelofibrosis

    Basabi Chatterjee, Usama Rqieh, P. Greaves, D. Piras +2 more

    2015British Journal of Haematology15 citations

    Semantic Scholar

    Save

15. A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications

    D. El-Sharkawi, A. Sud, Catherine Prodger, J. Khwaja +23 more

    2023Blood Cancer Journal14 citations Open access

    Semantic Scholar

    Save

16. Myeloablative chemotherapy for chemo-sensitive recurrent follicular lymphoma: potential benefit in second relapse

    S. Montoto, J. Matthews, P. Greaves, D. Lillington +3 more

    2013Haematologica13 citations Open access

    Semantic Scholar

    Save

17. A randomised evaluation of low‐dose cytosine arabinoside (ara‐C) plus tosedostat versus low‐dose ara‐C in older patients with acute myeloid leukaemia: results of the LI‐1 trial

    M. Dennis, A. Burnett, R. Hills, Ian Thomas +7 more

    2021British Journal of Haematology11 citations

    Semantic Scholar

    Save

18. Early relapse and refractory disease remain risk factors in the anthracycline and autologous transplant era for patients with relapsed/refractory classical Hodgkin lymphoma: a single centre intention‐to‐treat analysis

    P. Greaves, A. Wilson, J. Matthews, Daniel L. P. Brown +4 more

    2012British Journal of Haematology11 citations

    Semantic Scholar

    Save

19. Addition of plasma exchange to red cell exchange improves outcomes of fat embolism syndrome in sickle cell disease

    D. Tsitsikas, S. Rowe, Alessandra Bosch, Cai-Xia Hui +10 more

    2023British Journal of Haematology10 citations Open access

    Semantic Scholar

    Save

20. A single 1 g/kg dose of intravenous immunoglobulin is a safe and effective treatment for immune thrombocytopenia; results of the first HaemSTAR ‘Flash‐Mob’ retrospective study incorporating 961 patients

    Phillip L. R. Nicolson, R. Perry, R. Buka, Amelia Fisher +134 more

    2021British Journal of Haematology10 citations Open access

    Semantic Scholar

    Save

21. Posterior reversible encephalopathy syndrome following anti‐lymphocyte globulin treatment for severe aplastic anaemia

    P. Greaves, H. Oakervee, Samantha S. C. Kon, Randall Jones +1 more

    2006British Journal of Haematology9 citations

    Semantic Scholar

    Save

22. Demonstration of durable graft versus lymphoma effects in Hodgkin's lymphoma.

    P. Greaves, J. Gribben

    2011Journal of Clinical Oncology6 citations Open access

    Semantic Scholar

    Save

23. The PD1/PD-L1 Axis in the Classical Hodgkin Lymphoma Microenvironment: PD-1 Is Rarely Expressed but Identifies Patients with High-Risk Disease

    P. Greaves, A. Clear, A. Owen, A. Wilson +3 more

    20115 citations

    Semantic Scholar

    Save

24. An Immunohistochemical Score Based On CD68 and FOXP3 Expression In the Tumour Microenvironment at Diagnosis Defines Prognostic Groups In Both Early and Advanced Stage Classical Hodgkin Lymphoma

    P. Greaves, A. Clear, D. Owen, F. Macdougall +4 more

    20104 citations

    Semantic Scholar

    Save

25. A HaemSTAR-led, UK-wide 'flash-mob' audit of -intravenous immunoglobulin use in immune -thrombocytopenia.

    P. Nicolson, R. Perry, Amelia Fisher, Gemma Scott +132 more

    2019Clinical medicine (London)3 citations Open access

    Semantic Scholar

    Save

26. Lymphoid neoplasia. Laser-capturing the essence of Hodgkin lymphoma.

    P. Greaves, J. Gribben

    2012Blood3 citations Open access

    Semantic Scholar

    Save

27. Exploring the Immune Microenvironment of Diffuse Large B Cell Lymphoma in a Tissue Microarray: Predicting Survival with a Score That Incorporates Macrophages, Cytotoxic and Regulatory T Cells

    R. Coutinho, A. Clear, D. Owen, P. Greaves +5 more

    20113 citations

    Semantic Scholar

    Save

28. A case report of Adult Onset Still’s Disease and Kikuchi Fujimoto lymphadenitischallenges and learning points

    David Mathew, T. Doherty, Urmi Gupta, S. Todd +3 more

    20211 citations Open access

    Semantic Scholar

    Save

29. Parenthood in long‐term survivors after CHOP with or without etoposide treatment for aggressive lymphoma – response to Meissner et al

    P. Greaves, T. Lister, J. Gribben

    2014British Journal of Haematology1 citations Open access

    Semantic Scholar

    Save

30. microenvironment T-helper cells Defining characteristics of classical Hodgkin lymphoma

    M. Calaminici, J. Gribben, P. Greaves, A. Owen +3 more

    20131 citations

    Semantic Scholar

    Save

31. Inhibitory Ligands CD200, CD270, CD274 and CD276 Are Expressed On Eμ-TCL1 Transgenic Mouse Splenocytes and Are of Potential Relevance to Impaired T-Cell Function in Vivo

    Fabienne McClanahan, C. Ghirelli, P. Greaves, J. Riches +3 more

    20121 citations

    Semantic Scholar

    Save

32. The Relationship of Depression and Anxiety and Impact of Cancer in Long-Term Survivors of Haematological Malignancy.

    A. Korszun, Rachel Johnson, Shah-Jalal Sarker, Chowdhury Kashfia +9 more

    20121 citations

    Semantic Scholar

    Save

33. ABCL-184 Impact of MYC and BCL2 Double Expression on Outcomes in Primary CNS Lymphoma: A UK Multicenter Analysis

    Edward Poynton, E. Chernucha, James W. Day, Catherine Prodger +20 more

    2023Clinical Lymphoma, Myeloma & Leukemia0 citations Open access

    Semantic Scholar

    Save

34. Comparison of Outcomes Between Patients with MYC Rearranged DLBCL and Double/Triple Hit High-Grade B-Cell Lymphoma: A Pan-London Retrospective Review

    D. El-Sharkawi, Sarkhara Sharma, L. Cook, B. Hanley +25 more

    2019Clinical Lymphoma, Myeloma & Leukemia0 citations

    Semantic Scholar

    Save

35. Reduction in Gram Negative Rod Sepsis Rate in Intensively Treated Patients with AML Achieved through Identification of Unexpected Potential Environmental Source: A Successful Root-Cause Analysis

    W. Sin, F. Kenton, C. Hemmaway, Biju Krishnan +3 more

    20150 citations

    Semantic Scholar

    Save

36. Psychosocial Factors and Impact Of Cancer In British Long-Term Haematological Cancer Survivors

    A. Korszun, Shah-Jalal Sarker, K. Chowdhury, C. Clark +8 more

    20130 citations

    Semantic Scholar

    Save

37. A shot in the arm for radiotherapy.

    P. Greaves, J. Gribben

    2013Blood0 citations

    Semantic Scholar

    Save

38. The function and origin of the CD4+ T cell in the classical Hodgkin lymphoma microenvironment

    P. Greaves

    20120 citations

    Semantic Scholar

    Save

39. Pathology and clinico-pathological correlations

    S. Fogazzi, L. Arcaini, R. Zanotti, C. Bottelli +34 more

    20110 citations Open access

    Semantic Scholar

    Save

40. Fairest & Best Winners Country Week Fairest & Best Fairest & Best Winners Fariest & Best Winners Year Name Club Name Name Club Name Club

    K. Buswell, P. Nelson, S. Sisson, S. Sharpe +41 more

    20110 citations

    Semantic Scholar

    Save

41. Continuous CD4+ T Cell Lines Derived From the Classical Hodgkin Lymphoma Microenvironment: A Challenge to the Assumption of Anergy,

    P. Greaves, S. Iqbal, D. Taussig, J. Gribben

    20110 citations

    Semantic Scholar

    Save

42. Prospective Use of a Triple FISH Probe to Predict sMDS/AML Following High Dose Therapy with Autologous Stem Cell Rescue for Lymphoma.

    P. Greaves, S. Montoto, J. Matthews, A. Wilson +4 more

    20100 citations

    Semantic Scholar

    Save

43. A Single-Centre Analysis by Intention to Treat with High Dose Chemotherapy and Autologous Stem Cell Rescue Following Second-Line Treatment In Patients with Hodgkin Lymphoma

    P. Greaves, A. Wilson, J. Matthews, Daniel L. P. Brown +3 more

    20100 citations

    Semantic Scholar

    Save

44. Safe and efficacious use of recombinant human erythropoietin in malignancy.

    P. Greaves, S. Agrawal

    2007Clinical medicine (London)0 citations Open access

    Semantic Scholar

    Save

45. Optimising Haemoglobin Response to Exogenous Erythropoietin in Anaemic Patients Treated in Routine Haemato-Oncology Practice.

    S. Agrawal, P. Greaves, Christina Lim, C. Poole +1 more

    20060 citations

    Semantic Scholar

    Save